1.66
price down icon2.35%   -0.04
pre-market  プレマーケット:  1.64   -0.02   -1.20%
loading

Annovis Bio Inc (ANVS) 最新ニュース

pulisher
03:45 AM

What data driven models say about Annovis Bio Inc.’s futureTrade Ideas & Community Trade Idea Sharing - newser.com

03:45 AM
pulisher
03:09 AM

Can Annovis Bio Inc. stock hit record highs againMarket Growth Report & Entry Point Confirmation Alerts - newser.com

03:09 AM
pulisher
12:28 PM

Is Annovis Bio Inc. stock dividend yield sustainableQuarterly Profit Summary & Expert Verified Movement Alerts - newser.com

12:28 PM
pulisher
Oct 13, 2025

Cabaletta Bio Presents Early Clinical Data From RESET-PV Trial Showing Rese-Cel Activity Without Preconditioning - MyChesCo

Oct 13, 2025
pulisher
Oct 13, 2025

Heatmap analysis for Annovis Bio Inc. and competitorsTrade Risk Summary & Expert Curated Trade Setup Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Why Annovis Bio Inc. stock could be next big winnerAnalyst Downgrade & High Conviction Buy Zone Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Annovis Announces $6 Million Registered Direct Offering of Common Stock - MarketScreener

Oct 13, 2025
pulisher
Oct 13, 2025

How Annovis Bio Inc. stock trades during market volatility2025 Price Momentum & Smart Investment Allocation Tips - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Multi asset correlation models including Annovis Bio Inc.Market Rally & High Accuracy Trade Signal Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Full technical analysis of Annovis Bio Inc. stockJuly 2025 Opening Moves & Community Consensus Stock Picks - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Annovis Bio Reports Promising Biomarker Results Showing Anti-Inflammatory, Neuroprotective Effects of Buntanetap in Alzheimer’s Patients - MyChesCo

Oct 13, 2025
pulisher
Oct 10, 2025

Visual trend scoring systems applied to Annovis Bio Inc.Market Growth Review & Step-by-Step Trade Execution Guides - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Annovis Bio raises $6 million in registered direct offering By Investing.com - Investing.com South Africa

Oct 10, 2025
pulisher
Oct 10, 2025

Annovis Bio raises $6 million in registered direct offering - Investing.com India

Oct 10, 2025
pulisher
Oct 10, 2025

Annovis Bio to Raise $6 Million in Registered Direct Offering; Shares Fall - MarketScreener

Oct 10, 2025
pulisher
Oct 10, 2025

Annovis announces $6 million registered direct offering of common stock - MarketScreener

Oct 10, 2025
pulisher
Oct 10, 2025

Annovis Announces $6 Million Registered Direct Offering Of Common Stock - TradingView

Oct 10, 2025
pulisher
Oct 10, 2025

Annovis Bio, Inc. Announces $6 Million Registered Direct Offering of Common Stock - Quiver Quantitative

Oct 10, 2025
pulisher
Oct 10, 2025

Statistical indicators supporting Annovis Bio Inc.’s strengthJuly 2025 Reactions & Safe Capital Growth Tips - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Is Annovis Bio Inc. stock in buy zone after pullback2025 Market Outlook & Smart Money Movement Tracker - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Annovis (ANVS) Secures Patent Coverage for Both Forms of Buntanetap - MSN

Oct 09, 2025
pulisher
Oct 09, 2025

Annovis Bio Reports Buntanetap Shows Promising Biomarker Improvements in Alzheimer’s Patients - citybuzz

Oct 09, 2025
pulisher
Oct 09, 2025

Will Annovis Bio’s Therapeutic Innovation Drive Stock Growth? - timothysykes.com

Oct 09, 2025
pulisher
Oct 09, 2025

Annovis Bio reports buntanetap reduces inflammation in Alzheimer’s patients By Investing.com - Investing.com Australia

Oct 09, 2025
pulisher
Oct 09, 2025

Annovis Bio reports buntanetap reduces inflammation in Alzheimer’s patients - Investing.com

Oct 09, 2025
pulisher
Oct 09, 2025

Does Annovis Bio Inc. show high probability of reboundQuarterly Risk Review & Technical Entry and Exit Tips - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Annovis Bio Reports Promising Biomarker Results for Buntanetap in Alzheimer’s Disease Treatment - Quiver Quantitative

Oct 09, 2025
pulisher
Oct 09, 2025

Annovis Announces Novel Biomarker Data in Alzheimer’s Patients Supporting Buntanetap’s Potential as a Disease-Modifying Treatment - The Manila Times

Oct 09, 2025
pulisher
Oct 09, 2025

Annovis announces novel biomarker data in Alzheimer's patients supporting buntanetap's potential as a disease-modifying treatment - MarketScreener

Oct 09, 2025
pulisher
Oct 09, 2025

Annovis Announces Novel Biomarker Data in Alzheimer’s - GlobeNewswire

Oct 09, 2025
pulisher
Oct 09, 2025

Reduced IL-5, IL-6, S100A12, IFN-γ and NFL — Annovis' buntanetap shows biomarker signals in 2/3 AD - Stock Titan

Oct 09, 2025
pulisher
Oct 09, 2025

Will Annovis Bio Inc. stock go up soon2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Freedom Village at Brandywine Raises Over $6,000 for Alzheimer’s Research - MyChesCo

Oct 08, 2025
pulisher
Oct 07, 2025

What analysts say about Annovis Bio Inc stockGap Up/Gap Down Analysis & Ride the Trends That Billionaires Follow - earlytimes.in

Oct 07, 2025
pulisher
Oct 06, 2025

How high can Annovis Bio Inc. stock goQuarterly Portfolio Review & Safe Swing Trade Setups - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why Annovis Bio Inc. stock stays on buy listsJuly 2025 Action & Weekly Watchlist for Hot Stocks - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why analysts raise outlook for Annovis Bio Inc. stockQuarterly Trade Summary & Free Verified High Yield Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Why Annovis Bio Inc. stock is considered a top pickEarnings Performance Report & Weekly Setup with High ROI Potential - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Ipca Laboratories Limited Earnings Review What Investors Need to KnowRetail Investor Activity & Small Investment Wealth Growth - earlytimes.in

Oct 03, 2025
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
大文字化:     |  ボリューム (24 時間):